Ensign Peak Advisors, Inc Prime Medicine, Inc. Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

Shares

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 13, 2024	SELL	$4.3 - $8.03 $201,283 - $375,884	-46,810 Reduced 31.21%	103,190 $530,000
Q4 2022 Feb 13, 2023	BUY	$15.2 - $21.12 $2.28 Million - $3.17 Million	150,000 New	150,000 $2.79 Million

Others Institutions Holding PRME

# of Institutions

124

Shares Held

64.7M

Call Options Held

324K

Put Options Held

64.4K

Alphabet Inc. Mountain View, CA

15.1M
Shares

$50.5 Million
3.99% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

5.66M
Shares

$19 Million
0.21% of portfolio
Black Rock Inc. New York, NY

5.11M
Shares

$17.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.89M
Shares

$16.4 Million
0.0% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

3.81M
Shares

$12.8 Million
0.01% of portfolio

About Prime Medicine, Inc.

Ticker PRME
Shares Outstandng 95,730,200
Market Cap $321M

More about PRME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.